FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  HIRSCHMAN ORIN
 2. Date of Event Requiring Statement (Month/Day/Year)
06/13/2013		 3. Issuer Name and Ticker or Trading Symbol
Ohr Pharmaceutical Inc [OHRP]
(Last)
(First)
(Middle)
C/O OHR PHARMACEUTICAL, INC., 489 5TH AVENUE, 28TH FL.		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

NEW YORK, NY 10017		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $0.0001 per share 1,490,059
I
see footnotes (1) (2)
Common Stock 83,000
I
See footnote (3)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option 06/28/2012 06/28/2017 Common Stock 29,000 $ 3.6 I See footnotes (1) (2)
Warrant 04/18/2013 09/30/2014 Common Stock 337,481 $ 6.75 I See footnotes (1) (2)
Option 03/09/2012 03/09/2017 Common Stock 25,000 $ 1.71 D  
Option   (4) 03/09/2017 Common Stock 75,000 $ 1.71 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
HIRSCHMAN ORIN
C/O OHR PHARMACEUTICAL, INC.
489 5TH AVENUE, 28TH FL.
NEW YORK, NY 10017		   X   X    

Signatures

/s/ Orin Hirschman 06/24/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) AIGH Investment Partners ("AIGH") directly beneficially owns 1,490,059 Shares and directly beneficially owns an aggrergate of 366,481 Shares issuable pursuant to Derivative Securities.
(2) Orin Hirschman ("Hirschman") is the sole member of AIGH. Hirschman is in a position indirectly to determine the investment and voting decisions made by AIGH.
(3) Hirschman owns indirectly 83,000 Shares as custodian of accounts for the benefit of his seven minor children.
(4) These options to purchase common stock of the Issuer are exercisable over a 3 year period with 1/3 of the options granted vesting on an annual basis commencing on March 9, 2013.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.